Results 31 to 40 of about 405 (144)
Novel Antimicrobial Agents for Gram-Negative Pathogens
Gram-negative bacterial resistance to antimicrobials has had an exponential increase at a global level during the last decades and represent an everyday challenge, especially for the hospital practice of our era.
Marios Karvouniaris +6 more
doaj +1 more source
Background/purpose: This study aimed to investigate the in vitro susceptibilities of carbapenem-non-susceptible Pseudomonas aeruginosa (CNSPA) and Acinetobacter baumannii (CNSAB) isolates to cefiderocol, novel β-lactamase inhibitor (BLI) combinations ...
Po-Yu Liu +23 more
doaj +1 more source
Mechanistic basis for inhibition of the extended-spectrum β-lactamase GES-1 by enmetazobactam and tazobactam. [PDF]
β‐Lactamase‐catalysed hydrolysis is the primary form of β‐lactam antibiotic resistance in Gram‐negative bacteria. The penicillanic acid sulfone (PAS) enmetazobactam is thought to inhibit extended‐spectrum β‐lactamases (ESBLs) by fragmentation of an initial acyl‐enzyme to form an active‐site lysinoalanine cross link.
Beer M +10 more
europepmc +2 more sources
Fruits Vinegar : Quality Characteristics, Phytochemistry, and Functionality [PDF]
The popularity of fruits vinegar (FsV) has been increased recently as a healthy drink wealthy in bioactive compounds that provide several beneficial properties.
Bakour, Meryem +8 more
core +2 more sources
Antibacterial apple cider vinegar eradicates methicillin resistant Staphylococcus aureus and resistant Escherichia coli [PDF]
Methicillin-resistant Staphylococcus aureus (MRSA) and resistant Escherichia coli (rE.coli) infections can spread rapidly. Further they are associated with high morbidity and mortality from treatment failure.
Shah, A. +5 more
core +1 more source
Third-generation cephalosporin (3GC)-resistant Enterobacteriaceae are classified as critical priority pathogens, with extended-spectrum β-lactamases (ESBLs) as principal resistance determinants. Enmetazobactam (formerly AAI101) is a novel ESBL inhibitor developed in combination with cefepime for empirical treatment ...
Fabian Bernhard +9 more
openaire +3 more sources
Nuevos inhibidores de β-lactamasas frente a patógenos gram negativos multirresistentes [PDF]
Programa Oficial de Doutoramento en Ciencias da Saúde. 5007V01[Resumo] As especies Acinetobacter baumannii, Pseudomonas aeruginosa e a orde Enterobacterales son categorizados como patóxenos de prioridade crítica para o desenvolvemento de novos ...
Vázquez-Ucha, Juan Carlos
core
Carbapenemase Inhibitors: Updates on Developments in 2021 [PDF]
Carbapenem resistance, an emerging global health problem, compromises the treatment of infections caused by nosocomial pathogens. Preclinical and clinical trials demonstrate that a new generation of carbapenemases inhibitors, together with the recently ...
Allam, Sabine +7 more
core +1 more source
International ...
Vázquez-Ucha, Juan +8 more
openaire +4 more sources
Antibiotics needed to treat multidrug-resistant infections in neonates. [PDF]
Infections remain a leading cause of death in neonates. The sparse antibiotic development pipeline and challenges in conducting neonatal research have resulted in few effective antibiotics being adequately studied to treat multidrug-resistant (MDR ...
Agarwal, R +12 more
core +1 more source

